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Background:  The present study was conducted to evaluate the levels of interleukin (IL) – 17 in gingival 
crevicular fluid (GCF) and placental tissue samples of pregnant females as a possible marker in 
determining whether or not an association exists between chronic periodontitis and preterm labor. 
Methods:  This case-control study included a random sample of 40 female patients, aged 18 to 35 
years, who were assigned to one of the following four groups (10 subjects each): group 1 included 
patients who underwent spontaneous preterm birth (PB) and were diagnosed with chronic periodontitis 
upon clinical examination (preterm/periodontitis); group 2 included patients who underwent spontaneous 
PB and who had a healthy periodontium upon clinical examination (preterm/healthy periodontium); 
group 3 included patients who underwent spontaneous normal term birth and were diagnosed with 
chronic periodontitis upon clinical examination (term/periodontitis); and group 4 included patients who 
underwent spontaneous normal term birth and who had a healthy periodontium upon clinical examination 
(term/healthy periodontium). GCF and placental tissue samples were obtained from each patient and IL-
17 levels were measured using enzyme-linked immunosorbent assay (ELISA). Results: GCF levels of IL-17 
were significantly higher (P=0.010) in patients with chronic periodontitis compared to those with a 
healthy periodontium. No significant differences were observed in IL-17 levels in placental tissue samples 
of all study groups. Conclusion: An association between chronic periodontitis and preterm labor could 
not be established based on IL-17 levels measured in the present study. 
Key Words: Preterm labor; periodontal medicine; periodontitis; interleukin-17; gingival crevicular fluid.  
 
Introduction 
Pregnancy is normally a healthy 
physiological process that sometimes has 
adverse outcomes including low birth weight 
(LBW) (<2500 grams) and preterm birth (PB) 
(<37 weeks). PB is now the second most common 
cause of death worldwide in children younger 
than five years after pneumonia.1  As normal 
pregnancy progresses, amniotic fluid levels of 
prostaglandin E2 (PGE2) and inflammatory 
cytokines, such as tumor necrosis factor-alpha 
(TNF-α) and interleukin-1 beta (IL-1β) rise 
steadily until a critical threshold is reached to 
induce rupture of the amniotic sac membranes, 
uterine contraction, cervical dilation, and finally 
delivery.2  Thus, normal parturition is controlled 
by inflammatory signaling and this process 
represents a triggering mechanism that can be 
modified by external stimuli including infection 
and inflammatory stressors.3 
 Two major pathways have been 
proposed to trigger an inflammatory/immune 
response and/or suppression of local growth 
factors in the fetal-placental unit. The direct 
pathway suggests that oral microorganisms 
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and/or their components reach the fetal-
placental unit via hematogenous dissemination 
from the oral cavity, or via the genitourinary 
tract. The indirect pathway suggests that 
inflammatory mediators locally produced in 
periodontal tissues, for example PGE2 and  
TNF-α, circulate and impact the fetal-placental 
unit, or inflammatory mediators and/or microbial 
components circulate to the liver, enhancing 
cytokine production (e.g. IL-6) and acute phase 
response (e.g. C-reactive protein), which then 
impact the fetal-placental unit.1, 3  Numerous 
studies have associated an increase in the levels 
of local and systemic markers of inflammation 
with adverse pregnancy outcomes (APOs). 
Elevated levels of IL-1β, IL-6, TNF-α, PGE2, 
fibronectin, and α-fetoprotein in the amniotic 
fluid have been associated with PB.4 Increased 
maternal serum levels of pro-inflammatory 
cytokines, such as IL-1, IL-6, IL-8, and TNF-α, 
have also been reported to be associated with 
prematurity or LBW.5  Moreover, C-reactive 
protein (CRP), which is an acute phase reactant 
synthesized by the liver in response to pro-
inflammatory cytokines, and hence a marker of 
systemic inflammation, was also reported to be 
associated with PB.6 
 Periodontal diseases are a group of 
infectious/inflammatory diseases involving Gram 
negative, anaerobic, and microaerophilic 
bacteria that colonize the subgingival area and 
cause local and systemic elevations of pro-
inflammatory prostaglandins and cytokines, 
resulting in tissue destruction.3, 7  During 
pregnancy, due to physiological hormonal 
changes, there is a systematic inclination to 
periodontal disease. There is a global rise in 
anaerobic Gram-negative agents in particular, 
such as Fusobacterium nucleatum, Treponema 
denticola, Tannerella forsythia, and 
Campylobacter rectus.8  Moreover, especially 
during pregnancy, the hormonal changes due to 
elevated levels of estrogens and progesterone 
increase vascular permeability in the gingival 
tissues and, as a consequence, bacteria and/or 
their products can more readily diffuse through 
the tissues.  Evidence indicates that periodontal 
pathogens/byproducts may reach the fetal-
placental unit.3  In this context, Madianos et al. 
found that maternal serum immunoglobulin G 
(IgG) specific to oral organisms was associated 
with decreased PB and increased birth weight.  
In the presence of maternal oral organisms, the 
lack of a protective maternal IgG response 
could increase fetal exposure which may in turn 
contribute to a fetal immune response that could 
lead to PB.9  Porphyromonas  gingivalis and 
Aggregatibacter actinomycetemcomitans, both 
established periodontal pathogens, have also 
been found in the placenta of women with PB or 
pre-eclampsia.10 
In periodontally affected patients, there 
is an increase in the production of pro-
inflammatory cytokines and mediators from 
periodontal tissues. Once released, they may 
diffuse in the gingival crevicular fluid (GCF) or 
enter the blood circulation and reach the 
placenta-fetus interface. The production of 
prostaglandins could be stimulated by IL-1, IL-6, 
and TNF-α in the chorion, and in conjunction with 
the maternally derived PGE2 generated at the 
gingival level and released in the circulation, 
may exacerbate cervical ripening and uterine 
contraction leading to an increased risk for PB.3  
Interleukin (IL) – 17 is an important pro-
inflammatory cytokine which induces the 
expression of many mediators of inflammation 
and is critical to host defense. It has been 
reported that amniotic IL-17 levels were 
significantly higher in cases of preterm delivery 
compared to term delivery. In humans, IL-17 was 
identified first in CD4+T cells followed by CD8+T 
cells, γδ T cells, and monocytes. This cytokine has 
been linked to various chronic inflammatory 
conditions including: periodontitis, rheumatoid 
arthritis, inflammatory bowel disease, multiple 
sclerosis, and cancer. IL-17 binds to its receptor, 
IL-17 receptor A (IL-17 RA), and signals are 
transmitted through nuclear factor kappa-light-
chain-enhancer of activated B cells (NF-kB) and 
the mitogen-activated protein kinase (MAPK).11 
IL-17 has been reported to up-regulate IL-1β, 
TNF-α, and the tissue destructive matrix 
metalloproteinases (MMP) – 1 and 3 in 
periodontal disease. It also induces the 
production IL-6 and IL-8 from gingival 
fibroblasts.12  An increase has been reported in 
the amount of IL-17 in GCF samples and in the 
culture supernatants of gingival cells in 
periodontal disease.13 
Although a large number of 
epidemiological and intervention studies 
demonstrate a positive association between 
periodontal disease and APOs, the results are 
not always consistent.14   Therefore, the present 
study will be conducted to investigate the 
correlation between periodontal disease and PB 
by measuring the levels of IL-17, a highly 
sensitive novel inflammatory marker, in both 
GCF and placental tissues samples. 
Subjects and Methods 
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I - Patient Selection  
This case-control study was conducted at 
the Maternal-Fetal Medical Clinic at the 
Department of Obstetrics and Gynecology, 
Faculty of Medicine, Ain Shams University, Cairo, 
Egypt.  Forty eligible female patients aged 18 
to 35 years (mean: 25.95 years) were 
consecutively recruited to this study from 
December 2014 – March 2015. Inclusion criteria 
included: 1)  patients free of any systemic 
diseases as referenced from Burket’s Oral 
Medicine health history questionnaire;15 2) 
spontaneous normal term birth at ≥37 weeks of 
gestation without any obstetrical or medical 
complications; 3) spontaneous PB at <37 weeks 
of gestation after uterine contraction or rupture 
of membranes.16  Exclusion criteria included: 1) 
history of medications that may affect the study 
outcome, such as: current use of systemic 
corticosteroids or antibiotics for at least one 
month; 2) genital and urinary tract infections; 3) 
existing hypertension and diabetes mellitus 
before pregnancy, autoimmune disease, asthma, 
and chronic renal disease; 4) multiple 
pregnancies, cervical cerclage, abnormal 
placentation, past history of preterm delivery, or 
antepartum hemorrhage; and 5) low or high 
maternal body mass index.  All procedures 
performed in the present study were in 
accordance with the protocol approved by the 
Ain Shams University Research Ethics Committee. 
The nature and aim of the study was explained 
to each individual patient, and both verbal and 
written consents were obtained from all of the 
participants. All of the obtained information was 
treated with confidentiality. The study protocol 
was registered and identified as NCT03171675 
at the U.S. National Institutes of Health Clinical 
Trials Registry. 
 














SD = Standard deviation; Min. = Minimum value; Max. = Maximum value; dt = Duncan’s Multiple Range Test for 
the effect of group; Means with the same letter within each parameter are not significantly different at p=0.05. 
 
II - Clinical Evaluation and Patient Grouping 
 Patients who met the eligibility criteria 
received full-mouth periodontal examinations at 
the maternity ward within 24 hours postpartum.  
Full mouth baseline periodontal parameters 
were recorded for each patient, which included: 
plaque index (PI),17 gingival index (GI),18 
probing depth (PD),19 and clinical attachment 
level (CAL).19 All parameters were examined 
using a University of Michigan ʿOʾ Probe with 
William’s markings. Patients with ≥ 30 % full 
arch probing depth of >3 mm, who 
demonstrated periodontal clinical attachment 
loss, and who had a gingival index of 1-3, were 
diagnosed with chronic periodontitis.20  Subjects 
with a probing depth of ≤ 3 mm, who lacked 
periodontal clinical attachment loss, and who 
Parameter Group Mean SD Min. Max. dt 
Age (Years) 1 28.40 4.648 21 33 a 
2 24.50 4.503 18 35 a 
3 26.40 4.115 21 31 a 
4 24.50 4.905 18 32 a 
Gestation Duration (Weeks) 1 34.20 2.845 28.714 36.857 b 
2 33.20 4.188 23.857 36.714 b 
3 39.314 1.449 37.714 41.286 a 
4 38.457 0.796 37.429 39.857 a 
Parity 1 1.60 1.174 0 3 a 
2 1.00 0.943 0 3 a 
3 1.70 1.252 1 5 a 
4 1.30 0.823 0 3 a 
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had a gingival index of 0-0.5, were deemed to 
have a healthy periodontium. 
All participants were assigned to one of 
the following four groups (10 patients each): 
group 1 included patients who underwent 
spontaneous PB and were diagnosed with 
chronic periodontitis upon clinical examination 
(preterm/periodontitis); group 2 included 
patients who underwent spontaneous PB and 
who had a healthy periodontium upon clinical 
examination (preterm/healthy periodontium); 
group 3 included patients who underwent 
spontaneous normal term birth and were 
diagnosed with chronic periodontitis upon clinical 
examination (term/periodontitis); and group 4 
included patients who underwent spontaneous 
normal term birth and who had a healthy 
periodontium upon clinical examination 
(term/healthy periodontium). 
  

















SD = Standard deviation; Min. = Minimum value; Max. = Maximum value; dt = Duncan's Multiple Range Test for 
the effect of group; Means with the same letter within each measurement are not significantly different at p=0.05. 
 
III - Sample Collection 
GCF and placental tissue samples were 
obtained from each subject. Sterile absorbing 
paper stripsd were used to obtain GCF samples.  
For patients diagnosed with chronic periodontitis, 
a single sample was taken from the site 
possessing the highest PD along with the most 
clinical attachment loss; while for patients 
exhibiting a healthy periodontium, a random site 
was used to obtain the sample. Cotton gauze 
sponges were used to isolate the teeth being 
sampled and the absorbing paper strips were 
                                                 
d Periopaper™ , Oraflow, Smithtown, NY, USA 
11787 
gently placed into the gingival sulcus of the 
collection site until mild resistance was 
encountered, and were left in place for 
approximately 15 seconds.21  Each sample was 
placed into a cooled Eppendorf tube and stored 
at -80 ̊C for future use. Using a scalpel, a small 
piece of villous placental tissue (approximately 
1 cm3) was dissected free of the maternal 
decidua from the placental bed after delivery.  
Each sample was placed into a cooled 
Eppendorf tube and stored at -80 ̊C for future 
use. 
Clinical Periodontal Parameters Group Mean SD Min. Max. dt 
Plaque Index (PI) 1 2.6 0.516 2 3 a 
2 0.2 0.422 0 1 c 
3 1.9 0.316 1 2 b 
4 0.4 0.516 0 1 c 
Gingival Index (GI) 1 2.0 0.471 1 3 a 
2 0.0 0.000 0 0 b 
3 2.0 0.000 2 2 a 
4 0.0 0.000 0 0 b 
Probing Depth (PD) 1 4.1 0.316 4 5 a 
2 2.0 0.667 1 3 b 
3 4.2 0.422 4 5 a 
4 2.2 0.632 1 3 b 
Clinical Attachment Level (CAL) 1 1.2 0.422 1 2 a 
2 0.0 0.000 0 0 b 
3 1.3 0.483 1 2 a 
4 0.0 0.000 0 0 b 
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Enzyme-linked immunosorbent assay 
(ELISA)e was used to assess the level of IL-17 in 
each sample. The unopened kit was stored at 
approximately 5 ̊C.  This immunoassay is a 4.5 
hour solid phase ELISA built to measure human 
IL-17 in cell culture supernates, serum, 
andplasma.  It is comprised of E. coli-expressed 
human IL-17 and antibodies raised against the 
recombinant factor. 
 The duplicate readings for each 
standard, control, and sample were averaged, 
and the average zero standard optical density 
(O.D.) was subtracted. A standard curve was 
created by reducing the data using computer 
software capable of producing log/log curve-fit.  
IV - Statistical Analysis 
The primary objective of the present 
study was to evaluate the levels of IL-17 in GCF 
and placental tissue samples of both healthy and 
periodontally affected females who underwent 
PB. The secondary objective was to correlate 
clinical parameters with IL-17 levels in GCF and 
placental tissue samples. A power analysis was 
designed to have adequate power to apply a 
2-sided statistical test of the research hypothesis 
(Null hypothesis) that there was no difference 
between the two groups (chronic periodontitis 
and healthy periodontium).  According to the 
results of Vernal et al. (2005) and Beklen et al. 
(2007), and using a significance level (α) of 
0.05 and a power level (β) of 0.80, the 
predicted minimum sample size (n) was a total of 
4 cases i.e. 2 cases in each group (chronic 
periodontitis and healthy periodontium).  
Oversampling was done to overcome any 
suspected samples insufficiency. Sample size 
calculation was performed using the G*Power 
software (Version 3.1.9.2). 
Statistical analysis was carried out using 
the Statistical Package for the Social Sciences 
(SPSS) program (Release 17.0.0).  Descriptive 
statistics was calculated using Descriptive 
Statistics of SPSS (SPSS, analyze, Descriptive 
Statistics). Kolmogorov-Smirnov test of normality 
(SPSS, analyze, descriptive statistics, explore, 
plots, normality plots with tests) was run to test 
the normality of IL-17 in different groups. One 
way analysis of variance (SPSS, analyze, 
compare means, one way ANOVA) was used to 
test the effect of group on different 
measurements. Duncan Post-Hoc Multiple 
Comparisons (Post-Hoc) at p≤0.05 was used for 
comparison of means. Student t test (SPSS, 
                                                 
e Quantikine® ELISA, R&D Systems, Human IL-17 
analyze, compare means, independent-samples t 
test) was used to test the effect of periodontal 
status and gestation duration on mean IL-17 
levels in GCF and placental tissue samples. 
Spearman correlation (SPSS, analyze, correlate, 
bivariate) was used to test the correlation 
between mean IL-17 levels in GCF and placental 
tissue samples, gestation duration, and clinical 
periodontal parameters of all groups. 
Results 
No statistically significant differences 
were recorded in the periodontal parameters of 
the preterm and term/healthy periodontium 
groups. Similarly, the preterm/periodontitis 
group demonstrated insignificant differences 
compared to the term/periodontitis group, at 
p≤0.05, regarding the mean GI, PD, and CAL. 
The preterm/periodontitis group had a 
significantly higher mean PI compared to 
term/periodontitis study group (Table 2). 
Regarding the mean IL-17 levels in the 
GCF samples, a statistically significant 
difference was found between the 
term/periodontitis and term/healthy 
periodontium groups, with values at 
55.92±15.54 pg/ml and 42.94±8.25 pg/ml 
respectively (p<0.05). A statistically significant 
difference between the preterm/healthy 
periodontium and the term/periodontitis groups 
(p<0.05) was also recorded, while the 
preterm/periodontitis group demonstrated an 
insignificant difference when compared to the 
rest of the study groups at p=0.05 (Table 3).  
The chronic periodontitis and the healthy 
periodontium study groups demonstrated a 
statistically significant difference regarding the 
mean IL-17 levels in the GCF samples (p=0.01) 
(Table 4). However, no statistically significant 
difference was recorded for the preterm 
delivery and the term delivery groups 
(p=0.123) (Table 5). 
Regarding the mean IL-17 levels in the 
placental tissue samples, no statistically 
significant differences were demonstrated 
between all study groups at p=0.05. The highest 
level was found in the preterm/periodontitis 
study group, followed by the preterm/healthy 
periodontium study group, while the 
term/periodontitis study group demonstrated the 
lowest level (Table 3). No statistically significant 
difference was demonstrated between the 
chronic periodontitis and the healthy 
periodontium study groups regarding the mean 
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IL-17 levels in the placental tissue samples 
(p=0.550) (Table 4). Comparing the preterm 
delivery with the term delivery groups, no 
statistically significant difference was recorded 
(p=0.234) (Table 5). 
The term/periodontitis group 
demonstrated a positive, statistically significant 
correlation between the mean IL-17 level in 
placental tissue samples and the mean CAL at 
the 0.01 level. No other statistically significant 
correlations were recorded for IL-17 levels in 
GCF and placental tissue samples, gestation 
duration, and clinical periodontal parameters of 
all groups. No statistically significant correlations 
were observed between IL-17 levels in GCF 
samples and placental tissue samples of all study 
groups (Table 6).  
 
Table 3.  Descriptive statistics and test of significance for the effect of group on mean IL-17 levels in GCF 









SD = Standard deviation; Min. = Minimum value; Max. = Maximum value; dt = Duncan's Multiple Range Test for 
the effect of group; Means with the same letter within each measurement are not significantly different at p=0.05. 
 
 Table 4.  Effect of periodontal status on mean IL-17 levels in GCF and placental tissue samples 
 
SD = Standard deviation; P = Probability level for the effect of periodontal status (Student t test); NS = 
Insignificant (p>0.05); * = Significant at p≤0.01. 
 
 Table 5.  Effect of gestation duration on mean IL-17 levels in GCF and placental tissue samples 
 
SD = Standard deviation; P = Probability level for the effect of gestation duration (Student t test); NS = 
Insignificant (p>0.05). 
 
Measurement Group Mean SD Min. Max. dt 
IL-17 in GCF 
(pg/ml) 
1 47.092 15.969 23.86 66.14 ab 
2 38.264 8.415 25.42 51.88 b 
3 55.920 15.537 20.78 75.78 a 
4 42.938 8.250 28.50 55.04 b 
IL-17 in Placental Tissue 
(pg/g) 
1 136.520 30.824 98.30 197.50 a 
2 124.985 16.266 94.40 145.50 a 
3 120.035 33.877 59.65 169.35 a 
4 121.470 21.116 90.55 165.35 a 
Measurement Chronic Periodontitis Groups 
(Groups 1 & 3) 
Healthy Periodontium Groups 
(Groups 2 & 4) 
P 
Value 
Mean SD Mean SD 
IL-17 in GCF (pg/ml) 51.506 15.989 40.601 8.457 0.010* 
IL-17 in Placental Tissue 
(pg/g) 
128.278 32.637 123.228 18.433 
0.550 
NS 
Measurement Preterm Delivery Groups 
(Groups 1 & 2) 
Term Delivery Groups  
(Groups 3 &4) 
P 
Value 
Mean SD Mean SD 
IL-17 in GCF (pg/ml) 
42.678 13.223 49.429 13.818 
0.123 
NS 
IL-17 in Placental Tissue 
(pg/g) 
130.753 24.706 120.753 27.484 
0.234 
NS 
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Table 6.  Spearman ranked correlation coefficients between mean IL-17 levels in GCF and placental 























r = Correlation coefficient; p = Probability level; GD = Gestation duration; PT = Placental tissue; * Correlation is 
significant at the 0.01 level. 
 
Discussion 
Serious health problems are associated 
with preterm low birth weight (PLBW) infants 
including, neurodevelopment disturbances, ear 
infections, respiratory infections, asthma, and 
death.  Premature birth causes 10% of neonatal 
mortality worldwide.22  Despite immense medical 
advances, the rate of PB has not declined in the 
United States over the past several decades. The 
rate actually rose to more than 12% of all births 
in the year 2003.  Thus, identifying risk factors 
for PB, especially those that can be controlled or 
treated, would certainly have far-reaching and 
long-lasting effects.23 
Although it has been asserted that 
periodontopathogens from oral infection can 
disseminate to distant body sites and thus result 
in the delivery of PLBW infants, results have 
been inconclusive.24, 25, 26, 27  Some studies have 
demonstrated positive correlations, while others 
have not.28, 29, 30, 31, 32, 33, 34, 35  Although these 
results seem contradictory, factors such as race, 
geographical location, and socioeconomic 
standards have not been adequately adjusted 
for. Consequently, studies conducted in the 
United States and Europe differ from those 
conducted in Latin America or Africa, mainly due 
to a lack of adjustment for socio-economic 
factors, such as accessibility to adequate and 
affordable health care.23 
In the present study, IL-17 was chosen as 
a possible marker for preterm labor in patients 
with chronic periodontitis for several reasons. 
Since IL-17 has been found to up-regulate IL-1β
Correlations  Group 1 Group 2 Group 3 Group 4 
GCF IL-17 & GD r .267 -.259 -.488 -.110 
p .455 .470 .153 .763 
GCF IL-17 & PI r .178 .576 -.175 .036 
p .622 .087 .629 .922 
GCF IL-17 & GI r -.273 . . . 
p .445 . . . 
GCF IL-17 & PD r .058 -.276 .000 -.296 
p .873 .440 1.000 .407 
GCF IL-17 & CAL r -.175 . .229 . 
p .629 . .525 . 
GCF IL-17 & PT IL-17 r .373 -.277 .229 .488 
p .288 .438 .525 .153 
PT IL-17 & GD r -.104 .195 .268 -.537 
p .776 .589 .453 .110 
PT IL-17 & PI r -.107 -.175 .218 -.428 
p .768 .629 .545 .218 
PT IL-17 & GI r .196 . . . 
p .588 . . . 
PT IL-17 & PD r .350 .248 .218 -.452 
p .321 .489 .545 .190 
PT IL-17 & CAL r .525 . 1.000* . 
p .119 . . . 
GD & PI r .569 .218 .468 .606 
p .086 .545 .172 .063 
GD & GI r .156 . . . 
p .668 . . . 
GD & PD r .406 .469 .571 .379 
p .244 .171 .085 .280 
GD & CAL r .261 . .268 . 
p .466 . .453 . 
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 and TNF-α, it was proposed that its level 
increases in periodontitis, leading to an up-
regulation of these cytokines and tissue 
destructive matrix metalloproteinases (MMP) in 
local migrant and resident cells.  Elevated levels 
of IL-1β, TNF-α, and IL-17 have been found in 
periodontitis via immunocytochemistry.  These 
cytokines induced proMMP-1, and particularly 
MMP-3 in gingival fibroblasts. Although IL-17 
was less potent as a direct MMP-inducer than IL-
1β and TNF-α, it induced the production of IL-1β 
and TNF-α from macrophages, and IL-6 and IL-8 
from gingival fibroblasts. It was reported that 
gingival fibroblasts may play a significant role 
in periodontal tissue destruction through 
cytokine-inducible MMP-1 and MMP-3 
production, in which IL-17 acts as an important 
regulatory cytokine.12 
Cellular and humoral responses in both 
healthy individuals and those with periodontal 
disease have been detected through GCF 
analysis.21  In the present study, GCF was used 
to measure IL-17 levels associated with 
periodontitis since it is considered an excellent 
undispersed media for evaluating the released 
IL-17. Brill and Krasse inserted filter paper into 
the gingival sulci of dogs that had previously 
been given intramuscular fluorescein injections. 
The fluorescent material was absorbed on the 
paper strips within 3 minutes.  This demonstrated 
that fluid passed from the bloodstream through 
the tissues, and subsequently into the gingival 
sulcus. In later studies, Brill verified the presence 
of GCF in humans and considered it a 
“transudate.”36, 37, 38, 39  Sterile gingival fluid 
collection absorbing paper strips were used in 
the present study to obtain GCF samples due to 
their simplicity, convenience, and ease of use. 
The Brill technique, which involves inserting the 
absorbing paper strip into the sulcus until 
resistance is encountered, was used to obtain the 
GCF samples. This technique was chosen because 
it irritates the sulcular epithelium to some 
degree, subsequently leading to the flow of 
fluid.21 
In the present study, placental tissue 
samples were obtained from the subjects rather 
than amniotic fluid samples, due to the 
invasiveness of amniocentesis. Gram-negative 
periodontal bacteria and/or their virulence 
factors (e.g. endotoxins) have been shown to 
reach the systemic circulation, producing a low-
grade bacteremia. This is especially true during 
pregnancy, during which elevated levels of 
estrogen and progesterone increase vascular 
permeability in the gingival tissues, and 
consequently, diffusion of bacteria and/or their 
products occurs more readily. Immunological 
data has indicated that periodontal 
pathogens/byproducts may reach the fetal-
placental unit. Upon exposure of the mother to 
bacterial pathogens, an attempt will be made 
by the host’s immune response to contain and 
resolve the infection. If this is unsuccessful, then 
bacterial-specific antibodies will be produced 
by the more efficient adaptive immune 
response.3   
Although Keelan et al. reported 
increased cytokine levels in the gestational 
membranes of both term and preterm labor 
patients, signifying an inflammatory process, this 
process was not evident in the villous placenta. 
Thus, cytokine concentrations within placental 
tissues were not affected by labor.16  His study 
however lacked an exposure factor, as is the 
case in the present study, where two of the study 
groups were diagnosed with chronic 
periodontitis, a disease which has been 
associated with increased IL-17 levels.12, 13 
It has been hypothesized that PB may be 
precipitated by cytokines produced by the 
infected periodontium, which may reach the 
systemic circulation and subsequently target the 
placenta and fetus.40  Our results however, 
suggest that this is not the case given that the IL-
17 levels in GCF fluid did in fact increase in 
chronic periodontitis compared to our healthy 
periodontium groups, whereas this increase was 
not demonstrated in the IL-17 levels in placental 
tissue samples. 
The present study demonstrated a 
statistically significant difference between the 
term/periodontitis and the term/healthy 
periodontium groups regarding the mean IL-17 
levels in the GCF samples, with higher levels 
having been detected in the term/periodontitis 
study group. A statistically significant difference 
was also found (p=0.010) between mean IL-17 
levels in the GCF samples of the chronic 
periodontitis and healthy periodontium study 
groups, with levels being considerably higher in 
the chronic periodontitis study groups. These 
findings conform to those of Beklen et al. and 
Vernal et al., both of whom reported elevated 
IL-17 levels in periodontitis.12, 13  However, no 
statistically significant differences were found 
(p=0.123) regarding the mean IL-17 levels in 
the GCF samples of both preterm and term 
delivery groups. Furthermore, the results 
demonstrated no statistically significant 
differences, at p=0.05, between all study 
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groups regarding the mean level of IL-17 in 
placental tissue samples. These findings are 
consistent with those of Wood et al., Bassani et 
al., Abati et al., Souccar et al., and other authors 
who found no association between periodontitis 
and preterm labor.32, 33, 34, 35  
Conclusively, we could not establish an 
association between chronic periodontitis and 
preterm labor based on the measured IL-17 
levels in GCF and placental tissue samples in the 
present study. Despite limitations, including a 
small sample size and lack of intervention, this is 
a pioneer case-control study that can be added 
to the database of evidence-based research in 
this particular field of periodontology. 
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